Director of Hypertension Service and Hypertension Innovation Division of Endocrinology, Diabetes and Hypertension Brigham and Women’s Hospital

Dr. Fisher is an expert in the field of renal denervation (RDN). She served as site-PI for the RADIANCE-HTN trials with ultrasound-based RDN for mild, moderate and resistant hypertension, and she is the national co-PI of the RADIANCE-HTN RDN Continued Access Protocol.

Dr. Fisher directs the hypertension program for MassGeneralBrigham Innovation, which was built to replace the traditional office-based system of hypertension management with entirely remote, algorithmic, non-physician led treatment. To date several thousand patients have been enrolled.

Clinically, Dr. Fisher is Director of Hypertension Services at the Brigham and Women’s Hospital. She is a veteran teacher, directing courses at the Harvard Catalyst Clinical and Translational Science Center: Design of Clinical Trials, and Effectively Communicating Research.

Dr. Fisher received her Bachelor of Arts degree in the History and Philosophy of Science from Princeton University and her medical degree from the University of Pennsylvania. She completed residency at the Massachusetts General Hospital, followed by fellowship in Endocrinology, Diabetes and Hypertension as well as a research fellowship in Hypertension at the Brigham and Women’s Hospital in Boston.

Dr. Fisher has conducted dozens of clinical research trials at Harvard University, focusing on cardiovascular endocrinology. Her areas of research expertise include hypertension; renal denervation; cuffless blood pressure measurement; renal vascular hemodynamics; diabetes; and flavanols. Her bibliography includes original scientific reports, clinical guidelines, reviews, chapters and online resources.